|
cfMSC therapy for diabetes Clinical Trials
1 actively recruiting trial
Pipeline
Phase 1/2: 1
Top Sponsors
- Shenzhen Geno-Immune Medical Institute1
Indications
- Type II Diabetes Mellitus1
- Diabetes1
Other1 trial
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.